Pharmacists in Raeford, North Carolina


13 Pharmacists found in Raeford
female pharmacist

Dr. Amanda Toyer Crew, PHARM.D.


Pharmacist
210 Medical Pavilion Dr, Raeford, NC 28376
910-904-8095    

male pharmacist

Charles Allen, PHARM.D.


Pharmacist
221 Flagstone Ln, Raeford, NC 28376
910-565-1115     910-565-1113

female pharmacist

Dr. Cristina Del Mar Hernandez Lebron, PHARMD


Pharmacist
230 Cole Ave, Raeford, NC 28376
910-875-8501    



male pharmacist

Mr. Dwight Oxendine, RPH


Pharmacist
402 S Main St, Raeford, NC 28376
910-875-1032     910-848-0730

male pharmacist

Mr. George Sprite Barbee Iii, R.PH.


Pharmacist
415 Harris Ave, Raeford, NC 28376
910-875-6111     910-875-6111

female pharmacist

Hong Tran, PHARMD


Pharmacist
151 Chapel Hill Dr, Raeford, NC 28376
919-917-8882    

female pharmacist

Jameeka Marie Bridgeman, PHARMD


Pharmacist
300 Medical Pavilion Dr Ste 100, Raeford, NC 28376
910-904-8700    

male pharmacist

Mr. James Lee Brisson, B.S. PHARMACY


Pharmacist
230 Cole Avenue, Raeford, NC 28376
910-875-8501     910-875-1532

female pharmacist

Kelsey Nicole Lowery


Pharmacist
415 Harris Ave, Raeford, NC 28376
910-875-6111    

female pharmacist

Natalie Smith


Pharmacist
4545 Fayetteville Rd, Raeford, NC 28376
910-683-6110    

male pharmacist

Nshan Muradyan


Pharmacist
4545 Fayetteville Rd, Raeford, NC 28376
910-683-6110    

male pharmacist

Scott Thompson, PHARMD


Pharmacist
300 Medical Pavilion Dr Ste 100, Raeford, NC 28376
910-904-8700    

female pharmacist

Trang Thi Doan


Pharmacist
4545 Fayetteville Rd, Raeford, NC 28376
910-683-6110    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.